Ifetroban sodium clinical trials
A product of Ifetroban; its studies count on that page too.
How each study uses ifetroban sodium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ifetroban sodium studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Ifetroban Sodium
- 3
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 2
Vanderbilt-Ingram Cancer Center (1) · Jeffrey Rade (1) · Cumberland Pharmaceuticals (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Ifetroban
Studies
Open first, then newest update. How each study uses ifetroban sodium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingPhase 2Cumberland PharmaceuticalsNCT05571059Written as Ifetroban SodiumHow we know
- Thromboxane Receptor Antagonist to Improve Endothelial FunctionCompletedPhase 2Jeffrey RadeNCT03962855Written as Ifetroban SodiumHow we know
- Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceActive, not recruitingPhase 2Vanderbilt-Ingram Cancer CenterNCT03694249Written as Ifetroban SodiumHow we know
Codes
What other systems call ifetroban sodium · ClinicalTrials.gg INT014821
- UNII (FDA) 48IJA0E92CIFETROBAN SODIUMConfirmed FDA, Wikidata
- Wikidata Q27259142ifetroban sodiumConfirmed FDA, Wikidata
- NCI Thesaurus C81569Ifetroban SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 48IJA0E92C | IFETROBAN SODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q27259142 | ifetroban sodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C81569 | Ifetroban Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.